Leading pharmaceutical company Mankind Pharma has collaborated with Accenture to accelerate its digital transformation journey.
“As a part of the collaboration, Accenture has redesigned Mankind’s business processes across key functions such as finance, supply chain, sales and procurement for better inventory optimization, demand planning, workforce productivity, and product availability,” the statement said.
“Accenture has deployed a digital platform based on SAP S/4HANA®, a Microsoft Azure cloud-based data lake and Tableau dashboards, providing cloud-based analytics to help Mankind Pharma get deeper insights into its global business operations and performance,” the statement added.
“The company has also integrated data in real-time from multiple sources across the supply chain, workforce, and sales to provide a consolidated view of market insights. Which will help the management team make informed decisions around business strategy, planning, and product development,” the statement further said.
The project was completed remotely during the ongoing pandemic with no impact on business continuity.
Speaking on the collaboration, Arjun Juneja, chief operating officer, Mankind Pharma, said, “At Mankind Pharma, we are committed to product innovation so we can provide high quality and affordable pharmaceutical products to people across the world.”
“Digitally transforming our business processes with support from Accenture has been key to unlocking value trapped within the organization, accelerating real-time decision making, and improving our product innovation lifecycle,” Juneja added.
Commenting on the digital transformation, Rishabh Bindlish, India Life Sciences and global generics lead, Accenture, said, “Digital reinvention can not only help pharma companies deliver high-quality and hyper-personalized services, but also improve business performance and build resilience against future disruptions. We are focused on helping Mankind Pharma embrace change and emerge as a data-driven enterprise to enhance its customer-centricity bringing innovative offerings to market at a faster pace and scale for patients.”